Report on Antihypertensive Drug Market

May 2009 | 15 pages | ID: R6E3B182317EN
SunFaith China Ltd.

Abstracts

It is learned that China's hypertension morbidity rate of adults is 18.8%, treatment rate is 6.1%, and it also takes on a lowering trend of age, which attracting more and more people's attention on hypertension. Thus there is a greater demand for antihypertensive drug, and China's market scale of antihypertensive drug is still very huge in the future. This report carries out specific analysis and research of three major antihypertensive drug types, i.e.classification of current hypertension, and drug market competition. It points out that although there is a huge market demand of antihypertensive drug, the competition is still fierce.

Contents

1 INTRODUCTION OF HYPERTENSION

1.1 Classification
1.2 Types of antihypertensive drug

2 MARKET ANALYSIS OF ANTIHYPERTENSIVE DRUG

2.1 Market scale
2.2 Subdivison of market share
2.3 Market competition

3 CCB HYPOTENSOR

3.1 Amlodipine
3.2 Nifedipine
3.3 Felodipine

4 ARB HYPOTENSOR

4.1 Valsartan
4.2 Losartan Potassium
4.3 Irbesartan

5 BETA-BLOCKER HYPOTENSOR

5.1 Potassium magnessium aspartape
5.2 Metoprolol

6 ANALYSIS OF ANTIHYPERTENSIVE DRUG MARKET DEMAND

6.1 China's rising morbidity rate of hypertension
6.2 Low hypertension treatment rate and control rate
6.3 Huge market demand for antihypertensive drug

7 CONCLUSION